Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Budroni, Mario ^a   Cesaraccio, Rosaria ^a   Coviello, Vincenzo ^b   Sechi, Ornelia ^a   Pirino, Daniela ^a   Cossu, Antonio ^c   Tanda, Francesco ^c   Pisano, Marina ^d   Palomba, Grazia ^d   Palmieri, Giuseppe ^d  

^a Neurology Unit   (Italy)

^b ASL BA1   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA SEQUENCE; GENE FUNCTION; GENE MUTATION; GERM LINE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PREVALENCE; PROGNOSIS; SURVIVAL RATE; BREAST TUMOR; CANCER STAGING; FEMALE; GENETICS; MIDDLE AGED; MORTALITY; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; ITALY; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE; YOUNG ADULT;

EID: 62649111685     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-62     Document Type: Article

References (37)

1. Lønning PE Breast cancer prognostication and prediction: Are we making progress? Ann Oncol 2007, 18(Suppl 8):vIii3-7 10.1093/annonc/ mdm260 17890212
2. van't Veer LJ Dai H Vijver van de MJ He YD Hart AA Mao M Peterse HL Kooy van der K Marton MJ Witteveen AT Schreiber GJ Kerkhoven RM Roberts C Linsley PS Bernards R Friend SH Gene expression profiling predicts clinical outcome of breast cancer Nature 2002, 415:530-536 10.1038/ 415530a 11823860
3. Jarzabek K Koda M Kozlowski L Mittre H Sulkowski S Kottler ML Wolczynski S Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors Eur J Cancer 2005, 41:2924-34 10.1016/j.ejca.2005.09.010 16289616
4. Ford D Easton DF Bishop DT Narod SA Godgar DE Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium Lancet 1994, 343:692-695 10.1016/S0140-6736(94)91578-4 7907678
5. Easton DF Ford D Bishop DT Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers Am J Hum Genet 1995, 56:265-271 1801337 7825587
6. Easton DF Steele L Fields P Ormiston W Averill D Daly PA McManus R Neuhausen SL Ford D Wooster R Cannon-Albright LA Stratton MR Goldgar DE Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13 Am J Hum Genet 1997, 61:120-128 1715847 9245992 10.1086/513891
7. Ford D Easton DF Stratton M Narod S Goldgar D Devilee P Bishop DT Weber B Lenoir G Chang-Claude J Sobol H Teare MD Struewing J Arason A Scherneck S Peto J Rebbeck TR Tonin P Neuhausen S Barkardottir R Eyfjord J Lynch H Ponder BA Gayther SA Zelada-Hedman M Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 1998, 62:676-689 1376944 9497246 10.1086/301749
8. Kirova YM Stoppa-Lyonnet D Savignoni A Sigal-Zafrani B Fabre N Fourquet A Institut Curie Breast Cancer Study Group. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy Eur J Cancer 2005, 41:2304-11 10.1016/j.ejca.2005.02.037 16140006
9. Dent R Warner E Screening for hereditary breast cancer Semin Oncol 2007, 34:392-400 10.1053/j.seminoncol.2007.07.002 17920893
10. Metcalfe KA Lubinski J Ghadirian P Lynch H Kim-Sing C Friedman E Foulkes WD Domchek S Ainsworth P Isaacs C Tung N Gronwald J Cummings S Wagner T Manoukian S Møller P Weitzel J Sun P Narod SA Hereditary Breast Cancer Clinical Study Group. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: The Hereditary Breast Cancer Clinical Study Group J Clin Oncol 2008, 26:1093-7 10.1200/ JCO.2007.12.6078 18195327
11. Adem C Reynolds C Soderberg CL Slezak JM McDonnell SK Sebo TJ Schaid DJ Myers JL Sellers TA Hartmann LC Jenkins RB Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers Cancer 2003, 97:1-11 10.1002/ cncr.11048 12491499
12. Chappuis PO Nethercot V Foules WD Clinico-pathological characteristics of BRCA1 and BRCA2-related breast cancer Semin Surg Oncol 2000, 18:287-295 10.1002/ (SICI)1098-2388(200006)18:4<287::AID-SSU3>3.0.CO;2-5 10805950
13. Honrado E Benítez J Palacios J Histopathology of BRCA1- and BRCA2-associated breast cancer Crit Rev Oncol Hematol 2006, 59:27-39 10.1016/j.critrevonc.2006.01.006 16530420
14. Palacios J Honrado E Osorio A Cazorla A Sarrió D Barroso A Rodríguez S Cigudosa JC Diez O Alonso C Lerma E Sánchez L Rivas C Benítez J Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: Differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers Clin Cancer Res 2003, 9:3606-3614 14506147
15. Lakhani SR Jacquemier J Sloane JP Gusterson BA Anderson TJ Vijver van de MJ Farid LM Venter D Antoniou A Storfer-Isser A Smyth E Steel CM Haites N Scott RJ Goldgar D Neuhausen S Daly PA Ormiston W McManus R Scherneck S Ponder BA Ford D Peto J Stoppa-Lyonnet D Bignon YJ Struewing JP Spurr NK Bishop DT Klijn JG Devilee P Cornelisse CJ Lasset C Lenoir G Barkardottir RB Egilsson V Hamann U Chang-Claude J Sobol H Weber B Stratton MR Easton DF Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations J Natl Cancer Inst 1998, 90:1138-1145 10.1093/jnci/90.15.1138 9701363
16. The Breast Cancer Linkage Consortium. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases Lancet 1997, 349:1505-1510 10.1016/ S0140-6736(96)10109-4 9167459
17. Foulkes WD Chappuis PO Wong N Brunet JS Vesprini D Rozen F Yuan ZQ Pollak MN Kuperstein G Narod SA Begin LR Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome Ann Oncol 2000, 11:307-13 10.1023/A:1008340723974 10811497
18. Robson ME Chappuis PO Satagopan J Wong N Boyd J Goffin JR Hudis C Roberge D Norton L Begin LR Offit K Foulkes WD A combined analysis of outcome following breast cancer: Differences in survival based on BRCA1/ BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Res 2004:6 314444 14680495
19. Stoppa-Lyonnet D Ansquer Y Dreyfus H Gautier C Gauthier-Villars M Bourstyn E Clough KB Magdelenat H Pouillart P Vincent-Salomon A Fourquet A Asselain B Familial invasive breast cancers: Worse outcome related to BRCA1 mutations J Clin Oncol 2000, 18:4053-4059 11118466
20. Johannsson OT Ranstam J Borg A Olsson H Survival of BRCA1 breast and ovarian cancer patients: A population-based study from southern Sweden J Clin Oncol 1998, 16:397-404 9469321
21. Brekelmans CTM Seynaeve C Menke-Pluymers M Survival and prognostic factors in BRCA1-associated breast cancer Ann Oncol 2006, 17:391-400 10.1093/annonc/mdj095 16322115
22. Rennert G Bisland-Naggan S Barnett-Griness O Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations N Engl J Med 2007, 357:115-123 10.1056/NEJMoa070608 17625123
23. Palmieri G Palomba G Cossu A Pisano M Dedola MF Sarobba M Farris A Olmeo N Contu A Pasca A Satta M Persico I Carboni A Cossu-Rocca P Contini M Mangion J Stratton MR Tanda F BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling Ann Oncol 2002, 13:1899-1907 10.1093/annonc/mdf326 12453858
24. Palomba G Pisano M Cossu A Budroni M Dedola MF Farris A Contu A Baldinu P Tanda F Palmieri G Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian breast cancer patients through a hospital-based screening Cancer 2005, 104:1172-1179 10.1002/cncr.21298 16047344
25. Palomba G Cossu A Friedman E Budroni M Farris A Contu A Pisano M Baldinu P Sini MC Tanda F Palmieri G Origin and distribution of the BRCA2-8765delAG mutation in breast cancer BMC Cancer 2007, 7:132 1940259 17640379 10.1186/1471-2407-7-132
26. Budroni M Cesaraccio R Pirino D Sechi O Oggiano M Piras D Sechi A Cossu A Palmieri G Tanda F Cancer incidence in Sassari Province (1998-2002) Cancer Incidence in Five Continents, International Agency for Research on Cancer (IARC) Scientific Publications, No. 160 Lyon, IARC Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P 2007: IX
27. Hakulinen T Cancer survival corrected for heterogeneity in patient withdrawal Biometrics 1982, 38:933-942 10.2307/2529873 7168796
28. Verdecchia A Capocaccia R Hakulinen T Methods of data analysis Survival of cancer patients in Europe. The EUROCARE study. IARC scientific publication 95 Lyon International Agency for Research on Cancer Berrino F, SAnt M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J 1995.
29. Brenner H Hakulinen T Age adjustment of cancer survival rates: Methods, point estimates and standard errors Br J Cancer 2005, 93:372-5 10.1038/ sj.bjc.6602704 16052220
30. Mote PA Leary JA Avery KA Sandelin K Chenevix-Trench G Kirk JA Clarke CL Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor Genes Chromosomes Cancer 2004, 39:236-48 10.1002/gcc.10321 14732925
31. Veronesi A de Giacomi C Magri MD Lombardi D Zanetti M Scuderi C Dolcetti R Viel A Crivellari D Bidoli E Boiocchi M Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases BMC Cancer 2005, 5:70 1184063 15996267 10.1186/1471-2407-5-70
32. Musolino A Bella MA Bortesi B Michiara M Naldi N Zanelli P Capelletti M Pezzuolo D Camisa R Savi M Neri TM Ardizzoni A BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study Breast 2007, 16:280-92 10.1016/ j.breast.2006.12.003 17257844
33. Eerola H Vahteristo P Sarantaus L Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: A relative survival analysis from Finland Int J Cancer 2001, 93:368-72 10.1002/ ijc.1341 11433401
34. El-Tamer M Russo D Troxel A Survival and recurrence after breast cancer in BRCA1/2 mutation carriers Ann Surg Oncol 2004, 11:157-64 10.1245/ ASO.2004.05.018 14761918
35. Moller P Evans DG Reis MM Gregory H Anderson E Maehle L Lalloo F Howell A Apold J Clark N Lucassen A Steel CM Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status Int J Cancer 2007, 121:1017-1020 10.1002/ijc.22789 17471561
36. Barnett GC Shah M Redman K Easton DF Ponder BAJ Pharoah PDP Risk factors for the incidence of breast cancer: Do they affect survival from the disease? J Clin Oncol 2008, 26:3310-3316 10.1200/JCO.2006.10.3168 18612147
37. Brekelmans CT Seynaeve C Menke-Pluymers M Brüggenwirth HT Tilanus-Linthorst MM Bartels CC Kriege M van Geel AN Crepin CM Blom JC Meijers-Heijboer H Klijn JG Survival and prognostic factors in BRCA1-associated breast cancer Ann Oncol 2006, 17:391-400 10.1093/annonc/ mdj095 16322115